Ingalls & Snyder LLC’s Lipocine LPCN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | – | Sell |
-1,773
| Closed | -$389K | – | 373 |
|
|
2015
Q4 | $389K | Sell |
1,773
-10
| -0.6% | -$2.19K | 0.02% | 255 |
|
|
2015
Q3 | $358K | Sell |
1,783
-1,086
| -38% | -$218K | 0.02% | 257 |
|
|
2015
Q2 | $418K | Buy |
2,869
+301
| +12% | +$43.9K | 0.02% | 252 |
|
|
2015
Q1 | $301K | Sell |
2,568
-11
| -0.4% | -$1.29K | 0.02% | 288 |
|
|
2014
Q4 | $230K | Sell |
2,579
-240
| -9% | -$21.4K | 0.01% | 327 |
|
|
2014
Q3 | $292K | Buy |
2,819
+473
| +20% | +$49K | 0.02% | 296 |
|
|
2014
Q2 | $243K | Buy |
+2,346
| New | +$243K | 0.01% | 328 |
|